Emerging biopharma at first launch
Sampling, promotional review and payments set up before the field team starts.
A launch puts samples, promotional pieces and speaker programs in the field at the same time, and each one leaves a record a regulator can ask for. Agnotic Technologies builds the commercial systems a drug maker needs to launch within the rules, connected to the CRM and data platforms it already runs.
Trusted by global innovators
























Pharma commercial launch software is the set of systems a drug maker's commercial team needs to launch within the rules: HCP master data and engagement records, sample requests and accountability under PDMA, promotional review with Form FDA 2253 tracking, and transfers of value data for Open Payments. Agnotic Technologies builds and connects these systems for pharmaceutical companies.
Each of these turns into a scramble before an audit or a reporting deadline.
Sample requests are signed on paper or in one app, and the signature cannot be linked to the delivery record.
The annual sample inventory does not reconcile with the last one, and nobody can show why.
The piece a representative shows is not the version that was approved.
Nobody knows the date a piece was first used, so the Form FDA 2253 submission is late or missing.
Speaker program meals and fees are rebuilt from expense reports when the Open Payments report is due.
The same physician appears three times across CRM, sampling and events, with different licence numbers.
Withdrawn or expired material stays on representatives' tablets.
Three choices that make every report a query instead of a project.
One record per prescriber, with identifiers such as NPI and State licence numbers, used by CRM, sampling, events and payments alike.
Each promotional piece carries its approved version, expiry date and the date it was first disseminated, so the 2253 package can be prepared on time.
Meals, fees and travel are recorded against the HCP master when they happen, not reconstructed from expenses at year end.
Systems we build, extend or connect around your existing commercial stack.
Matching and survivorship rules across CRM, sampling, events and third-party reference data.
Calls, events and materials used, tied to the HCP and the approved piece.
Written requests with the fields PDMA requires, captured before delivery.
Representative inventories, transfers and the annual physical count reconciled with the last one.
Medical, legal and regulatory review with versions, comments and approvals on record.
First-use dates captured and the submission package prepared for your regulatory team.
Payments and other transfers recorded against the HCP master for annual reporting.
Launch dashboards for sampling, content in use and HCP data quality.
The workflow we build for each piece, with every step recorded.
Claims linked to the references that support them.
Each reviewer comments on a version, and every version is kept.
Approval, approvers and an expiry or review date recorded.
At first dissemination, the piece and the current professional labeling are packaged for your regulatory team to submit.
Only the approved version reaches representative tablets, email templates and the web.
Which representatives showed which piece to which HCP, and when.
Expired or withdrawn pieces are pulled from every channel at once.
We work with the platforms you license and fill the gaps between them.
Measures we build into the launch dashboard.
Requests with signatures, deliveries and open discrepancies.
Pieces in the field on their approved version, and any past expiry.
Transfers of value recorded when they happened, not at year end.
Duplicates, missing identifiers and lapsed licences.
A HIPAA-ready maternal health platform enabling remote patient monitoring, care coordination, and personalized engagement from pre-pregnancy through postpartum.


A women’s health product experience focused on guided care journeys, education, and compliance-aware workflows to support long-term engagement.
Teams that need regulated workflows, not another sales tool.
Sampling, promotional review and payments set up before the field team starts.
Smaller field teams with complex speaker programs.
Reporting that comes from records instead of spreadsheets.
Evidence for sampling, promotion and payments in one place.
Clear separation between medical and promotional engagement records.
Commercial records moved without losing the audit trail.
The systems around the HCP master.
Our launch readiness checklist: each regulated commercial activity, the record the software must hold and the rule behind it. Your compliance and regulatory teams own the policies; the software holds the evidence.
We build secure, scalable products designed for privacy, interoperability, and regulatory readiness from day one across every sector we serve.
Implement lawful consent flows, data minimization, and secure processing for global data privacy.
We combine deep technical expertise with industry-specific knowledge to deliver solutions that aren't just functional, but transformational.
We implement rigorous security protocols and compliance standards (HIPAA, GDPR, SOC2) across all industrial solutions to protect sensitive data.
Our architectures are built to handle massive data loads and user bases, keeping performance steady whether you're serving ten or ten million.
Using our suite of internal tools and proven frameworks, we cut setup work so your first release reaches users sooner.
Beyond simple wrappers, we build deep-learning integrations and predictive analytics directly into the core of your industry-specific workflows.
We build in launch order. Timing depends on scope; we agree a fixed first release on the scoping call.
We review your launch plan, field model and the commercial systems you already license.
Which activities start when, and the records each one needs from day one.
The activity that starts first, usually sampling or promotional review, working end to end.
Transfers of value capture and launch dashboards added on the HCP master.
Changes for new indications, products and field teams under change control.
Short facts we design the sampling, promotion and payment records around, each linked to its primary source.
A drug sample delivered by a representative needs a written request signed by the licensed practitioner before delivery, and the request must include the practitioner's name, address, title, State license number, the drug, its strength and the quantity requested.
Source: 21 CFR 203.31(a)(1) and (b) (eCFR)A manufacturer that distributes drug samples through representatives must conduct a complete physical inventory of all samples at least annually and reconcile the results with the most recent prior inventory.
Source: 21 CFR 203.31(d) (eCFR)The applicant must submit specimens of promotional labeling and advertising at the time of initial dissemination or publication, each accompanied by a completed Form FDA-2253 and a copy of the product's current professional labeling.
Source: 21 CFR 314.81(b)(3)(i) (eCFR)Applicable manufacturers must report to CMS each year the direct and indirect payments or other transfers of value they provided to covered recipients during the preceding calendar year.
Source: 42 CFR 403.904(a)(1) (eCFR)We don't just build products; we forge lasting partnerships. See how we've helped industry leaders transform their vision into technical reality.

“I can clearly see how Agnotic has a unique way of handling end-to-end development. They are always active on quick chat and provide support quickly.”
Aaron Phelan
Founder, Benchmark

“Agnotic combines deep technical expertise with strong domain knowledge. They understand the business context, anticipate challenges, and make collaboration smooth and effective.”
John Pasmore
Founder, Latimer
“Agnotic is the best technical team we evaluated. Their engineering excellence made our work dramatically easier and allowed us to stay focused on what matters most for maternal care outcomes. They took full ownership of the technical execution, and we are always happy to continue working together.”
Kim Smith
Founder, My Lauren
This page covers regulated commercial workflows. These pages cover the rest of a drug maker's systems.
Pharmacovigilance, quality, DSCSA and GxP-aligned systems.
Hub services, enrollment and adherence support.
Software for sponsors, CROs and research teams.
Reporting layers for commercial and operations teams.
Research-ready data from EHR, claims and registries.
Explore other production-grade engineering platforms we deliver across healthcare.
The technical patterns behind this platform translate naturally into adjacent verticals.